Cancer patient bought ticket for assisted death, then three injections stopped his suffering
A cancer patient abandoned plans to die in Switzerland after doctors ended relentless itching by targeting an immune pathway linked to allergies; Prof. Yuval Tal explains how immunology is moving beyond disease labels to treat underlying mechanisms
A cancer patient, exhausted from years of severe itching despite being in remission, purchased a ticket to seek assisted death in Switzerland. However, upon learning that the itching was not caused by the cancer, doctors identified the root cause as a type 2 inflammation process involving cytokines. Subsequently, three injections targeting this immune pathway significantly alleviated the patient's symptoms.
The once tormented individual then destroyed his travel ticket to Switzerland. This case is not unique, as doctors have since observed similar improvements in other patients with severe itching linked to cancer or its treatment. These cases highlight the critical importance of identifying the specific immune pathway driving a condition, even when its origin is unclear.
This shift in medical understanding demonstrates the expanding scope of immunology, influencing various medical fields beyond allergy research, including oncology, rheumatology, dermatology, and more.
Written by urgent.news from Ynetnews Culture's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
